
According to doctors, patients in the U.S. taking high doses of Novo Nordisk's weight-loss drug, Wegovy, are facing difficulties in filling their prescriptions. Walgreens, one of the largest U.S. pharmacies, confirmed experiencing supply shortages for the higher strengths. Novo Nordisk stated that there were no interruptions in the supply of the highest doses, but doctors from six states reported delays in filling prescriptions. Patients who miss their weekly injections may experience severe side effects.
Like
Save
Share